1. Contractors
  2. Octapharma USA Inc.

Octapharma USA Inc.

Federal contractor · Biological Product (except Diagnostic) Manufacturing

Octapharma USA has 10 federal contracts of $100,000 or more active since October 2023, with $15.2M obligated, from 1 agency. None is running now.

Contracts
10 since FY2024$15,220,000 obligated, contracts of $100,000 or more
Running now
None9 ended in the last 12 months
Biggest customer
Defense Health Agency$15.2M on 10 contracts
UEI
FKJKNJVR1HV4Unique entity ID in SAM.gov
Source
USAspending.govUpdated Nov 17, 2026, 7:02 PM UTC

Contracts by start year

Obligated so far on contracts active since October 2023, by the fiscal year each started. Fiscal years run Oct 1 to Sep 30.
Show as table
Fiscal yearContracts
FY2025$5,500,000
FY2026$9,720,000

Running contracts

No contract of $100,000 or more is running now.

Who they work for

AgencyAmount
Defense Health Agency10 contracts$15,220,000

What they sell

IndustryAmount
Biological Product (except Diagnostic) ManufacturingNAICS 325414 · 10 contracts$15,220,000

Where the work is

Place of workAmount
New Jersey5 contracts$7,920,000
California2 contracts$3,600,000
Maryland2 contracts$3,600,000

Source: USAspending.gov, prime contracts of $100,000 or more with an action since October 1, 2023. Department of Defense contracts appear there about 90 days after award. Other contracts ending soon at Defense Health Agency: see the list.

Get new notices like Octapharma USA's work

New contract opportunities under NAICS 325414, biological product (except diagnostic) manufacturing, the morning they appear. Free while in beta.

Free. We use your email only for these alerts and never share it. Privacy